Listed Company Uses Raised Funds for Stock Speculation, Loses 27 Million, Borrows Money to Fill the Gap

Jinhua Enterprise (Group) Co., Ltd. (Jinhua Group) suffered a loss of 27 million RMB due to stock speculation using raised funds, resulting in the need to borrow money to cover the shortfall. The company borrowed money for 5 days, incurring interest of 100,000 RMB.

According to the Daily Economic News on December 4th, 2023, Jinhua Group conducted over 20 stock and fund transactions, with a total investment of 1.51 billion RMB in securities and sales amounting to 1.47 billion RMB, resulting in a loss of 27.4671 million RMB through stock speculation.

The funds used by Jinhua Group for stock trading were sourced from raised funds intended for “new plant relocation and expansion,” initially scheduled for completion by the end of 2021 but delayed to the end of 2024, a delay of nearly 3 years. As of the first half of 2024, the project had a committed total of 480 million RMB, with an accumulated investment of 212 million RMB, achieving only 44.07% progress.

A portion of the raised funds was used for stock trading, and investment losses prevented the company from fully repaying this portion to the raised fund account by the year-end of 2023. In December 2023, Jinhua Group had to temporarily borrow 30 million RMB from a natural person to fulfill the fund repayment.

The company’s announcement revealed that on December 4th, 2023, a natural person named Yang Bin provided a loan of 30 million RMB to Jinhua Group at a monthly interest rate of 2%, generating 100,000 RMB in interest. The loan term was 5 days and was intended for replenishing the raised funds. The announcement did not mention stock trading, stating that the funds were for the company’s operational liquidity.

With reference to the Daily Economic News, the annual report of Jinhua Group indicated that the company started stock trading in 2022, earning a profit of 2.8848 million RMB. However, in 2023, the company faced a loss of 27.4671 million RMB. In the first half of this year, the company invested 615 million RMB in securities, with sales amounting to 555 million RMB, resulting in an investment loss of -7.396 million RMB.

Public data shows that Jinhua Enterprise (Group) Co., Ltd. is a high-tech listed company specializing in biopharmaceuticals and pharmaceutical logistics industries. It was listed on the Shanghai Stock Exchange on June 12, 1997.

The company’s annual report revealed a gradual decline in performance in recent years. From 2019 to 2023, the company’s operating income was 755 million RMB, 668 million RMB, 534 million RMB, 579 million RMB, and 565 million RMB respectively. The net profit attributable to the parent company was 25.9027 million RMB, 37.738 million RMB, -18.1605 million RMB, 33.4595 million RMB, and -42.8906 million RMB respectively. The non-net profit attributable to the parent company was 13.3851 million RMB, 25.9225 million RMB, 35.8534 million RMB, 3.813 million RMB, and 3.0047 million RMB respectively.

In the first half of this year, Jinhua Group’s revenue was 2.46 billion RMB, down 3.68% year-on-year, while the net profit attributable to the parent company was 9.4629 million RMB, an increase of 211.01% year-on-year, and the non-net profit was 10.0314 million RMB, down by 42.39% year-on-year.